SPDEF along with KRASG12D induced malignant mucinous lung tumors (tubulopapillary‐like carcinoma; Fig EV3B), while KRASG12D itself induced benign non‐mucinous lung tumors (Fig EV3B). Here, SPDEF is linked to carcinoma.